IR Contacts

Members of the financial community, institutional and individual investors, and members of the media seeking additional information on Questcor are invited to contact:

Doug Sherk
EVC Group, Inc.
415-652-9100

Gregory Gin
EVC Group, Inc.
646-445-4801

Mailing Address:
Questcor Pharmaceuticals, Inc.
1300 N. Kellogg Ste D
Anaheim,CA
90807



Questions can also be submitted through the form below. Fields marked with an * are required.

 
 
 
 
 
 
This helps Questcor Pharmaceuticals, Inc. prevent automated submissions.